Randomized, double blind, placebo controlled dose ranging study of Tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty - Kereiakes, DJ; Kleiman, NS; Ambrose, J; Cohen, M; Rodriguez, S; Palabrica, T; Herrmann, HC; Sutton, J; Weaver, WD; McKee, D; Fitzpatrick, V; Sax, FL (J Am Coll Cardiol, 1996)